Vaccine-induced protection against murine schistosomiasis mansoni with larval excretory-secretory antigens and papain or type-2 cytokines (Q39551535)

13 September 2017

Vaccine-induced protection against murine schistosomiasis mansoni with larval excretory-secretory antigens and papain or type-2 cytokines (English)

1 reference

13 September 2017

0 references

0 references

schistosomiasis mansoni

1 reference

Rashika El Ridi

1

1 reference

13 September 2017

Hatem Tallima

series ordinal

2

1 reference

13 September 2017

language of work or name

1 reference

17 September 2012

1 reference

13 September 2017

9

1 reference

based on heuristic

inferred from page(s)

published in

Journal of Parasitology

1 reference

13 September 2017

99

1 reference

13 September 2017

2

1 reference

13 September 2017

194-202

1 reference

on focus list of Wikimedia project

13 September 2017

ScienceSource

0 references

cites work

Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence

1 reference

Coinfection of Schistosoma (Trematoda) with bacteria, protozoa and helminths

21 January 2018

1 reference

In vitro cellular and humoral responses to Schistosoma mansoni vaccine candidate antigens

21 January 2018

1 reference

Schistosomiasis vaccine:research to development

21 January 2018

1 reference

Biology of the eosinophil

21 January 2018

1 reference

Schistosomes: the road from host-parasite interactions to vaccines in clinical trials

21 January 2018

1 reference

The Trichuris muris system: a paradigm of resistance and susceptibility to intestinal nematode infection

21 January 2018

1 reference

Polymorphism associated with the Schistosoma mansoni tetraspanin-2 gene

21 January 2018

1 reference

Identification of novel proteases and immunomodulators in the secretions of schistosome cercariae that facilitate host entry.

21 January 2018

1 reference

A DNA-prime/protein-boost vaccination regimen enhances Th2 immune responses but not protection following Schistosoma mansoni infection

21 January 2018

1 reference

Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy.

21 January 2018

1 reference

Interleukin-13 in the skin and interferon-gamma in the liver are key players in immune protection in human schistosomiasis

21 January 2018

1 reference

Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection.

21 January 2018

1 reference

Human and murine humoral immune recognition of multiple peptides from Schistosoma mansoni glyceraldehyde 3-P dehydrogenase is associated with resistance to Schistosomiasis

21 January 2018

1 reference

Immunogenicity and vaccine potential of dipeptidic multiple antigen peptides from Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase

21 January 2018

1 reference

Human T- and B-cell responses to Schistosoma mansoni recombinant glyceraldehyde 3-phosphate dehydrogenase correlate with resistance to reinfection with S. mansoni or Schistosoma haematobium after chemotherapy

21 January 2018

1 reference

Equilibrium in lung schistosomula sphingomyelin breakdown and biosynthesis allows very small molecules, but not antibody, to access proteins at the host-parasite interface.

21 January 2018

1 reference

Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis

21 January 2018

1 reference

Innate immunogenicity and in vitro protective potential of Schistosoma mansoni lung schistosomula excretory--secretory candidate vaccine antigens

21 January 2018

1 reference

Efficacy and mechanism of action of arachidonic acid in the treatment of hamsters infected with Schistosoma mansoni or Schistosoma haematobium

21 January 2018

1 reference

Decision-model estimation of the age-specific disability weight for schistosomiasis japonica: a systematic review of the literature

21 January 2018

1 reference

Comparison of Schistosoma mansoni irradiated cercariae and Sm23 DNA vaccines.

21 January 2018

1 reference

Schistosomiasis elimination: lessons from the past guide the future

21 January 2018

1 reference

Proteomic analysis of skin invasion by blood fluke larvae

21 January 2018

1 reference

Thymic stromal lymphopoietin

21 January 2018

1 reference

Intravascular immunity: the host-pathogen encounter in blood vessels.

21 January 2018

1 reference

No overt cellular inflammation around intravascular schistosomes in vivo.

21 January 2018

1 reference

Mechanisms of resistance to S. mansoni infection: the rat model.

21 January 2018

1 reference

Parasites and poverty: the case of schistosomiasis

21 January 2018

1 reference

Proteomic analysis of Schistosoma mansoni cercarial secretions

21 January 2018

1 reference

Biophysical studies of the schistosome surface and their relevance to its properties under immune and drug attack

21 January 2018

1 reference

Helminth products bypass the need for TSLP in Th2 immune responses by directly modulating dendritic cell function

21 January 2018

1 reference

Nuocytes and beyond: new insights into helminth expulsion.

21 January 2018

1 reference

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

21 January 2018

1 reference

Fluorescent imaging of antigen released by a skin-invading helminth reveals differential uptake and activation profiles by antigen presenting cells

21 January 2018

1 reference

Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni

21 January 2018

1 reference

Systemically dispersed innate IL-13-expressing cells in type 2 immunity

21 January 2018

1 reference

Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels

21 January 2018

1 reference

Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites

21 January 2018

1 reference

Basophils beyond effector cells of allergic inflammation

21 January 2018

1 reference

21 January 2018

Schistosomiasis vaccines

1 reference

TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation

21 January 2018

1 reference

A mechanism for the initiation of allergen-induced T helper type 2 responses

21 January 2018

1 reference

Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response

21 January 2018

1 reference

Role of basophils in the initiation of Th2 responses

21 January 2018

1 reference

Evaluation of cholesterol content and impact on antigen exposure in the outer lipid bilayer of adult schistosomes

21 January 2018

1 reference

Differences in immunogenicity and vaccine potential of peptides from Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase

21 January 2018

1 reference

The T helper type 2 response to cysteine proteases requires dendritic cell-basophil cooperation via ROS-mediated signaling.

21 January 2018

1 reference

Peptides and multiple antigen peptides from Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase: preparation, immunogenicity and immunoprotective capacity in C57BL/6 mice

21 January 2018

1 reference

Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1645/GE-3186.1

1 reference

13 September 2017

1 reference